Newsroom

Electron microscope image
News
An international research group led by the Helmholtz Centre for Infection Research (HZI) has discovered a promising new drug candidate against severe lung infections caused by the hospital germ Staphylococcus aureus. The study, which has just been published in Cell Host & Microbe, describes for the first time how small molecules from the quinoxalinedione class specifically block the bacterial toxin α-hemolysin – a key trigger of tissue damage and inflammation.
01.04.2025
Florian Hubrich and Mariia Nesterkina
News
Acquiring external funding is an integral part of any young scientist’s path towards an independent research career. Such additional funds not only make their own scientific success visible, but also give them freedom to implement new and possibly riskier project ideas. One funding instrument that focuses on supporting early stage researchers is the Klaus-Tschira-Boost-Fund. In the current round of applications, 15 out of more than 300 applicants were selected to receive funding of up to 120,000 Euros each – amongst them the junior researchers Mariia Nesterkina and Florian Hubrich from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University. As so-called “Boost Fellows”, Mariia Nesterkina and Florian Hubrich benefit not only from the funding itself, but also from a series of workshops on career development and gain access to extensive career counseling and coaching services. The funded projects are set to start between April and October 2025 and will run for 24 months.
01.04.2025
Teaser for the podcast episode with Martin Korte
News
How do viruses and bacteria affect our cognitive abilities? What role do they play in neurodegenerative diseases like Alzheimer’s and dementia? And how can we protect our brain in the long term? In this episode of the HZI podcast InFact, Prof. Martin Korte, head of the research group “Neuroinflammation and Neurodegeneration” at the Helmholtz Centre for Infection Research (HZI), discusses the links between infections, the immune system, and the brain.
26.03.2025
Illustration of a large monocyte surrounded by smaller red blood cells
News
Not only does our body change with age, but so does our immune system. A recent study led by the Centre for Individualised Infection Medicine (CiiM) shows exactly how immune cells age and how infections and vaccinations can influence this process. The CiiM is a joint initiative of the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH). Using a big data approach, the researchers have developed a computer model called the “Single-Cell Immune Aging Clock”, which can be used to determine aging processes within individual immune cells. The scientists are making the innovative aging clock freely available for further research. They hope that it will serve as a useful tool to better understand the aging processes of the immune system, particularly with the context of infectious diseases and immune disorders. The study has been published in the journal Nature Aging.
19.03.2025
Wild snake stew
Interview
Bushmeat, the meat of wild animals hunted for food, is consumed across cultures and considered a delicacy in most parts of the world. Especially in sub-Saharan Africa, it still represents a major fraction of the proteins consumed. However, the close contact between humans and diverse tropical wildlife species — potentially harboring a wide variety of pathogens — poses a significant risk for the transmission of zoonotic diseases. The project "BehaviorChange: Co-creating and evaluating behavioral change interventions for reducing the zoonotic risk associated with wildlife consumption" aims to characterize the zoonotic risks associated with bushmeat consumption in Côte d’Ivoire and Liberia, and to understand its socio-economical drivers.
14.03.2025
Portrait Prof Dr Fabian Leendertz
News
Regarding the current reporting on the origin of the coronavirus SARS-CoV-2, Prof. Fabian Leendertz, Director of the Helmholtz Institute for One Health (HIOH), makes the following statement: “Based on the data published to date, it can be assumed that the transmission to humans took place via intermediate hosts (e.g. animal farms), as the contacts and risks are much higher there. This data has been published in various WHO reports and relevant peer-reviewed scientific publications. If there is now other and new data that supports an origin in the laboratory, then that is a different picture. We now have to wait until this data has been examined and reviewed by experts.”
13.03.2025

HZI in the media

... ” Seit Mai 2025 im Humanprogramm des Helmholtz-Zentrums für Infektionsforschung (HZI), Dr. Max Kellner-Leiter der jungen ...

25.09.2025
|
Die heutigen Nachrichten

” (Vico) within the Human program at the Helmholtz Centre for Infection Research (HZI).the‌ Vico group continues to investigate resilience

25.09.2025
|
World Today News

Forschende des Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz-Zentrums für ...

19.09.2025
|
Verband Deutscher Biologen e.V.

purposes.

 

Researchers at the HIRI, a site of the Braunschweig Helmholtz Center for Infection Research (HZI), in cooperation with the Julius

19.09.2025
|
NewsBreak

... ihr Team vom Helmholtz-Institut für One Health (HIOH) in Greifswald – einem Standort des Helmholtz-Zentrums ...

18.09.2025
|
Management & Krankenhaus

... der TU Braunschweig, dem Braunschweig Integrated Centre of Systems Biology (BRICS) und dem Helmholtz-Zentrum für ...

15.09.2025
|
DeutschesGesundheitsPortal

Das Institut ist ein Teil des rennommierten Helmholtz-Zentrums für Infektionsforschung ...

11.09.2025
|
NDR Norddeutscher Rundfunk

... gearbeitet werden soll. Greifswald (dpa/mv) - In einem eigenen Gebäude sollen Forscher des Helmholtz-Instituts ...

11.09.2025
|
n-tv

Direktor des Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI) in Würzburg, einem Standort des Braunschweiger Helmholtz- ...

11.09.2025
|
MTA Dialog

Studie und Hersteller des Prüfpräparats. Das Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) war bei ...

11.09.2025
|
Kölner News Journal

at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Institute of Molecular Infection Biology (IMIB) in Würzburg has

10.09.2025
|
Phys.org

Leiter der Abteilung Chemische Biologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig www.helmholtz-hzi.de ...

10.09.2025
|
BR Bayerischer Rundfunk

Register now for the HZI-Newsletter